Literature DB >> 8876381

Excimer laser corneal surgery and free oxygen radicals.

K Bilgihan1, A Bilgihan, F Akata, B Hasanreisoğlu, N Türközkan.   

Abstract

Corneal photoablation with 193 nm argon fluoride excimer laser is a new technique for the treatment of refractive errors and for removing corneal opacities and irregularities. Ultraviolet radiation and thermal injury induce free radical formation in the tissues. The aim of this study was to confirm the production of free radicals by excimer laser photoablation in rabbits. The thermal changes of the posterior corneal surface were recorded during excimer laser photoablation. The lipid peroxide (LPO) levels and superoxide dismutase (SOD) activities of aqueous humour were measured after excimer laser keratectomy. The aqueous LPO levels were not changed after excimer laser ablation, but both the thermal increase in the cornea during the photoablation and the decreased aqueous SOD activities suggest that free radicals are formed in the cornea during excimer laser keratectomy, and that they may be responsible for some of the complications of excimer laser corneal surgery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876381

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  3 in total

1.  Corneal aldehyde dehydrogenase and glutathione S-transferase activity after excimer laser keratectomy in guinea pigs.

Authors:  K Bilgihan; A Bilgihan; B Hasanreisoğlu; N Turkozkan
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

2.  Excimer Laser Corneal Refractive Surgery in the Clinic: A Systematic Review and Meta-analysis.

Authors:  Huang Zhang; Mingming Li; Zhimin Cen
Journal:  Comput Math Methods Med       Date:  2022-06-15       Impact factor: 2.809

3.  Oral l-Cysteine Supplementation Enhances the Long Term-Effect of Topical Basic Fibroblast Growth Factor (bFGF) in Reducing the Corneal Haze after Photorefractive Keratectomy in Myopic Patients.

Authors:  Alessandro Meduri; Loredana Bergandi; Pietro Perroni; Francesca Silvagno; Pasquale Aragona
Journal:  Pharmaceuticals (Basel)       Date:  2020-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.